Innate Pharma S.A. (IPHA) First Half 2022 Financial Results and Business Update Transcript

Innate Pharma S.A. (NASDAQ:IPHA) First Half 2022 Financial Results and Business Update September 15, 2022 8:00 AM ET Company Participants Henry Wheeler – Investor Relations Mondher Mahjoubi – Chief Executive Officer Joyson Karakunnel – Executive Vice President and Chief Medical Officer Yannis Morel – Executive Vice President-Business Development and Product Portfolio Strategy Frédéric Lombard – Chief Financial Officer Conference Call Participants Carly Kenselaar – Citi Daina Graybosch – SVB Securities Nick ...